pharmacie et médicaments – Plafonnement des remises accordées aux pharmaciens

This written question concerns the capping of rebates granted to pharmacists in France. It seeks clarification on the potential impact of such measures on the pharmaceutical sector and the accessibility of medicines. The question addresses pharmacists, pharmaceutical companies, and potentially patients, by examining the financial mechanisms within the drug distribution chain and their consequences.